Girard Sharp LLP and Motley Rice LLC Announce a Proposed Settlement in In re Xyrem (Sodium Oxybate) Antitrust Litigation

SAN FRANCISCO, July 28, 2023 /PRNewswire/ — Proposed Settlement and Certification of Classes in Lawsuit Involving the Drugs Xyrem and Xywav A class action lawsuit is pending in the United States District Court for the Northern District of California (the “Court”). Plaintiffs in the…

Click here to view original post

Advertisement — Advertise with Biotech Networks